Nobuya Inagaki

Active 1989–2025

165
Papers
19,562
Citations
81
h-index
155
i10-index

Citations

Citations per year for Nobuya Inagaki1991: 5 citations1992: 14 citations1993: 18 citations1994: 35 citations1995: 32 citations1996: 81 citations1997: 119 citations1998: 168 citations1999: 188 citations2000: 152 citations2001: 106 citations2002: 123 citations2003: 127 citations2004: 109 citations2005: 115 citations2006: 97 citations2007: 105 citations2008: 95 citations2009: 89 citations2010: 109 citations2011: 132 citations2012: 127 citations2013: 120 citations2014: 106 citations2015: 139 citations2016: 146 citations2017: 142 citations2018: 132 citations2019: 551 citations2020: 574 citations2021: 595 citations2022: 474 citations2023: 318 citations2024: 582 citations2025: 311 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,703 citing papers, 22.4% of this breakdownJapan: 1,018 citing papers, 13.4% of this breakdownChina: 684 citing papers, 9% of this breakdownUnited Kingdom: 570 citing papers, 7.5% of this breakdownGermany: 418 citing papers, 5.5% of this breakdownItaly: 278 citing papers, 3.7% of this breakdownCanada: 259 citing papers, 3.4% of this breakdownFrance: 223 citing papers, 2.9% of this breakdownAustralia: 180 citing papers, 2.4% of this breakdownSpain: 145 citing papers, 1.9% of this breakdownDenmark: 139 citing papers, 1.8% of this breakdownSouth Korea: 139 citing papers, 1.8% of this breakdown
0%22.4%Other 24.3%

Fields

  • Medicine66.7%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Neuroscience6.1%
  • Immunology and Microbiology2.5%
  • Nursing1%
  • Agricultural and Biological Sciences0.6%
  • Other2.7%

Topics

  • Diabetes Treatment and Management6.5%
  • Pancreatic function and diabetes5.6%
  • Metabolism, Diabetes, and Cancer3.5%
  • Ion channel regulation and function2.5%
  • Cardiac Ischemia and Reperfusion2.4%
  • Diabetes Management and Research2.1%
  • Other77.4%

Coauthors

All papers

Open in search
  1. Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

    Authors: , , , , - The Lancet Diabetes & Endocrinology 2022 cited by 211

  2. Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hideki Nishimura, Akira Numata, T. Ohama, Tomoko Okabe, FUMINOBU OKUGUCHI, Takeshi Osonoi, T Sasaki, Hiroaki Seino, Koki Shin, Toshihiko Shiraiwa, Toshiyuki Sugiura, Seiki Wada, Akira Yamauchi - The Lancet Diabetes & Endocrinology 2020 cited by 203

  3. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding

    Authors: , , , , , , , , , , , , , , , , , , , , - JCI Insight 2023 cited by 65

  4. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells

    Authors: , , - Frontiers in Endocrinology 2022 cited by 117

  5. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults

    Authors: , , , , , , , - Nutrition 2016 cited by 543

  6. The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption

    Authors: , , , , , , , , , - Endocrinology 2007 cited by 305

  7. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

    Authors: , , , , , , , , , , , , - Diabetology International 2010 cited by 1,771

  8. Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 145

  9. Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells

    Authors: , , - Biomolecules 2022 cited by 65

  10. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shozo Miyauchi, Tomikazu Fukuoka, Shoichiro Izawa, Takashi Yoneda, Shigeatsu Hashimoto, Toshihiko Yanase, Tomoko Suzuki, Takashi Kawamura, Yasuharu Tabara, Fumihiko Matsuda, Mitsuhide Naruse, Nagahama Study*, Takahisa Kawaguchi, Kazuya Setoh, Fumihiko Matsuda, Yoshimitsu Takahashi, Takeo Nakayama, Shinji Kosugi - Hypertension 2018 cited by 199

  11. Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor

    Authors: , , , , , , , , - Science 1995 cited by 1,724

  12. Chronic Reduction of GIP Secretion Alleviates Obesity and Insulin Resistance Under High-Fat Diet Conditions

    Authors: , , , , , , , , , - Diabetes 2014 cited by 171

  13. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration

    Authors: , , , , , , , , , , , , , , - Leukemia 2008 cited by 156

  14. Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2014 cited by 155

  15. Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2019 cited by 135

  16. Free Fatty Acid Receptor GPR120 Is Highly Expressed in Enteroendocrine K Cells of the Upper Small Intestine and Has a Critical Role in GIP Secretion After Fat Ingestion

    Authors: , , , , , , , , , , , , , , - Endocrinology 2014 cited by 126

  17. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet–Fed Mice

    Authors: , , , , , , , , , , , - Diabetes 2017 cited by 95

  18. Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice

    Authors: , , , , , , , , , , , , , , , , - Diabetes 2011 cited by 111

  19. High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shintaro Okamura, Shozo Miyauchi, Tomikazu Fukuoka, Shoichiro Izawa, Shigeatsu Hashimoto, Masanobu Yamada, Yuichiro Yoshikawa, Tatsuya Kai, Tomoko Suzuki, Takashi Kawamura, Mitsuhide Naruse - Diabetes Care 2019 cited by 95

  20. Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular and renal outcomes: A meta‐analysis and meta‐regression analysis

    Authors: , , , , , - Diabetes Obesity and Metabolism 2022 cited by 37

  21. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study

    Authors: , , , , , , , , , , , , , - Thyroid 2017 cited by 172

  22. Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , - Advances in Therapy 2016 cited by 141

  23. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hypertension 2019 cited by 68

  24. GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells

    Authors: , , , , , , , , , , , , , , , - Scientific Reports 2019 cited by 43